CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-center clinical study enrolling up to 50 participants. The primary objective of the study is to evaluate the safety of Alpha DaRT in...
Orlando, Florida, United States and 14 other locations
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Orlando, Florida, United States and 12 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Orlando, Florida, United States and 108 other locations
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.
Phase 1
Orlando, Florida, United States and 11 other locations
This is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as wel...
Phase 1
Orlando, Florida, United States and 15 other locations
The main goal of this study is to evaluate the safety of BNT329 and to identify the best dose of BNT329. This will be done by measuring the number of...
Phase 1, Phase 2
Orlando, Florida, United States and 16 other locations
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and r...
Phase 1
Orlando, Florida, United States and 11 other locations
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumor...
Phase 2
Orlando, Florida, United States and 27 other locations
The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the s...
Phase 1, Phase 2
Orlando, Florida, United States and 12 other locations
The goal of this clinical trial is to evaluate FMC-376 in participants with advanced solid tumors with KRAS G12C mutations. This clinical trial will...
Phase 1, Phase 2
Lake Mary, Florida, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal